Wakefield Express on MSN

COPD clinical trial: Mid Yorkshire Teaching NHS Trust recruits first patient to new COPD clinical trial

Mid Yorkshire Teaching NHS Trust has become the first site in Europe to recruit a patient to a major international clinical ...
WAVY-TV

Circulogene Announces Exclusive Commercial Launch of LungLifeAI® for Indeterminate Pulmonary Nodule Assessment

PENSACOLA, Fla., May 13, 2025 /PRNewswire/ -- Circulogene is excited to announce the exclusive commercial launch of LungLifeAI®, a breakthrough AI-driven blood-based test designed to improve clinical ...
Business Wire

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its ...
Pharmaceutical Technology on MSN

GSK forges pact with Empirico for respiratory siRNA in $745m deal

GSK now has the global development and commercialisation rights to the COPD-targeting oligonucleotide, EMP-012.
PharmExec

GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate

Shortly following the announcement of its acquisition of Syndivia’s ADC, GSK entered into a worldwide exclusive license agreement with Empirico for its leading clinical-stage respiratory disease ...